Waarde Capital
Waarde Capital partners with exceptionally talented entrepreneurs and executives to build valuable businesses.
Business Model:
Revenue: $6.9M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Waarde Capital Information
Geographic Data
Address: 26 Pravdy Street
City: Moscow
State: moscow (city)
Zip: 125040
Country: RU
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Waarde Capital is an investment company founded by entrepreneurs for entrepreneurs. As such, they are well positioned to identify and support best companies with strong entrepreneurs. With three active funds under management, including LBO, growth equity, and venture fund, it invests practically on every stage of the business lifecycle, and do it globally. Waarde invests in Europe, US, Israel, Africa, and Southeast Asia. Waarde Capital brings funding and assists in the strategic development of portfolio companies and, if necessary, offers debt financing that may significantly increase the value of the co-owned equity. Waarde Capital invests in Africa, Europe, SEA and United States. Waarde Capital’s management team brings about 150 years of accumulated business experience of it&s;s partners in Russia and other countries. Managing partners are skilled entrepreneurs who became professional investors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2016 | Gauzy | Series B | 21.5M |
| 11/2014 | GetGoing | Convertible Note | - |
| 11/2021 | Sabi Am | Bridge | 6M |
| 3/2017 | Exon Lab | Venture Round | - |
| 6/2012 | GetGoing | Private Equity Round | - |
| 2/2013 | GetGoing | Convertible Note | - |
| 12/2020 | Bartini Aero | Seed Round | - |
| 12/2021 | Octonic | Seed Round | 1M |
| 12/2021 | MAX | Series B | 0 |
| 12/2016 | Xplenty | Venture Round | 0 |
| 4/2014 | Bioxis Pharmaceuticals | Convertible Note | - |
| 1/2013 | Bioxis Pharmaceuticals | Convertible Note | - |
| 8/2012 | Bioxis Pharmaceuticals | Private Equity Round | - |
| 3/2022 | KOKO Networks | Funding Round | - |
| 3/2022 | HyPoint | Convertible Note | - |
| 3/2016 | Utilight | Convertible Note | 2.9M |
| 2/2022 | Gauzy | Series D | 70M |
| 10/2014 | Xplenty | Series A | 3M |
| 8/2021 | Sabi Am | Seed Round | 0 |
| 3/2022 | KOKO Networks | Funding Round | - |
| 3/2022 | HyPoint | Convertible Note | - |
| 2/2022 | Gauzy | Series D | 0 |
| 12/2021 | MAX | Series B | 0 |
| 11/2021 | Sabi Am | Convertible Note | 0 |
| 8/2021 | Sabi Am | Seed Round | 0 |
| 12/2020 | Bartini Aero | Seed Round | - |
| 3/2017 | Exon Lab | Venture Round | - |
| 12/2016 | Xplenty | Venture Round | 0 |
| 10/2016 | Gauzy | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
